CA
NZ
UK
AU
IND
US
The recent environmental permit secured by BHP for the Escondida copper mine expansion is set to boost copper output, supporting the growing demand for the metal in the renewable energy sector. This development is expected to have a significant impact on the mining sector, …
Equinox Gold’s latest production figures signal a strengthening trend for the broader gold mining sector. The company’s output lift, coupled with a pending merger, may buoy equities tied to precious metals and support sector‑wide price movements.
Severe alopecia areata remains a difficult-to-treat autoimmune condition in which the body's immune system attacks hair follicles, often leading to extensive and psychologically distressing hair loss. While JAK inhibitors from larger pharmaceutical companies have reshaped the treatment landscape in recent years, they carry boxed …
TACTI-004 was designed to evaluate eftilagimod alfa (efti) in combination with pembrolizumab and chemotherapy in a larger, pivotal-stage NSCLC population, building on encouraging earlier-stage data for the drug. The trial's discontinuation followed disappointing results, but the nature of those results — specifically a suppressed …
The $1.00 minimum bid price rule is one of Nasdaq's core continued-listing standards, designed to ensure that companies trading on the exchange maintain a share price reflecting a baseline level of market confidence and liquidity. Companies that fall below this threshold for an extended …
ROBBIN1 is a registration-directed study evaluating a neoadjuvant combination of BOT (botensilimab) and BAL (balstilimab) in patients with microsatellite-stable (MSS) colon cancer, a genetic subtype that has historically responded poorly to immunotherapy. Neoadjuvant treatment means the combination is given before surgery, with the goal …
Late-line metastatic cancer studies, by their nature, treat patients whose disease has progressed after multiple prior lines of therapy. These settings are notoriously difficult for demonstrating strong efficacy signals, both because the patient population is more heavily pretreated and because meaningful survival benefits are …
Chief Medical Officers play a central role in clinical-stage biotech companies, typically overseeing trial design, regulatory strategy, and the medical and scientific narrative the company presents to investors, physicians, and agencies like the FDA. A CMO departure ahead of major trial milestones can introduce …
Endoscopic sympathectomy refers to a minimally invasive procedure targeting the sympathetic nervous system, which regulates a wide array of involuntary bodily functions including heart rate, blood pressure, and pain signaling. Autonomix's platform is designed to combine sensing technology — which can detect and map …
PREA generally requires companies developing new drugs to study their safety and effectiveness in pediatric populations, but it also recognizes that testing unproven therapies in children before adult data are available can raise ethical and safety concerns, particularly for serious, high-mortality conditions like bacteremia. …
Please wait processing your request...